Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function

Platelets

Volumn 26, Issue 2, 2015, Pages 154-163

  Osman, Abdimajid ^a   Hitzler, Walter E ^b   Meyer, Claudius U ^b   Landry, Patricia ^c,d   Corduan, Aurélie ^c,d   Laffont, Benoit ^c,d   Boilard, Eric ^c,d   Hellstern, Peter ^e   Vamvakas, Eleftherios C ^f   Provost, Patrick ^c,d  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e KLINIKUM LUDWIGSHAFEN   (Germany)

^f NONE   (United States)

Author keywords

MicroRNA; Pathogen reduction; Platelet; Platelet function; Transfusion medicine

Indexed keywords

ADENOSINE DIPHOSPHATE; AMOTOSALEN; CLUSTERIN; MESSENGER RNA; MICRORNA; PROTEIN BCL XL; PROTEIN BCL X; TRANSCRIPTOME;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; GAMMA IRRADIATION; HUMAN; HUMAN CELL; PATHOGEN REDUCTION SYSTEM; PRIORITY JOURNAL; RNA SYNTHESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; BLOOD STORAGE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE VOLUME;

BCL-X PROTEIN; BLOOD PLATELETS; BLOOD PRESERVATION; CLUSTERIN; GENE EXPRESSION PROFILING; HUMANS; MEAN PLATELET VOLUME; MICRORNAS; PLATELET ACTIVATION; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84922783109     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2014.898178     Document Type: Article

References (57)

1. Roth GJ, Hickey MJ, Chung DW, Hickstein DD. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun 1989;160(2):705-710.
2. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118(14):e101-e111.
3. Tsao CH. Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol 1971;8(2):134-140.
4. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 1987;164(1):189-195.
5. Booyse FM, Rafelson Jr ME. Studies on human platelets. I. synthesis of platelet protein in a cell-free system. Biochim Biophys Acta 1968; 166(3):689-697.
6. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A 1998;95(10):5556-5561.
7. Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L, Tacconelli S, Sacchetti A, DAngelo S, Scilimati A, et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 2006;98(5):593-595.
8. Edelstein LC, Bray PF. MicroRNAs in platelet production and activation. Blood 2011;117(20):5289-5296.
9. Osman A, Falker K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011;22(6):433-441.
10. Ple H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One 2012;7(12):e50746.
11. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;16(9):961-966.
12. Bruchova H, Merkerova M, Prchal JT. Aberrant expression of microRNA in polycythemia vera. Haematologica 2008; 93(7):1009-1016.
13. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, Lopez JA, Yang L, et al. Platelet microRNA- mRNA coexpression profiles correlate with platelet reactivity. Blood 2011;117(19):5189-5197.
14. Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q, Whiteheart SW, Shaw C, et al. VAMP8/ endobrevin is overexpressed in hyperreactive human platelets: Suggested role for platelet microRNA. J Thromb Haemost 2010; 8(2):369-378.
15. Wollowitz S. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 2001;38(4 Suppl 11):4-11.
16. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: The SPRINT trial. Blood 2004;104(5):1534-1541.
17. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: Making decisions about new technologies. Report of a consensus conference. Transfusion 2007;47(12):2338-2347.
18. Kerkhoffs JL, van Putten WL, Novotny VM, Te Boekhorst PA, Schipperus MR, Zwaginga JJ, van Pampus LC, de Greef GE, Luten M, Huijgens PC, et al. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol 2010; 150(2):209-217.
19. van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Kluter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial. Blood 2003;101(6):2426-2433.
20. Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010;50(11):2362-2375.
21. Vamvakas EC. Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets. Transfusion 2011;51(5):1058-1071.
22. Vamvakas EC. Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system. Vox Sanguinis 2012;102(4):302-316.
23. Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: The SPRINT trial. Transfusion 2005; 45(12):1864-1875.
24. Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF. Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev 2013;3: CD009072.
25. Fang Z, Du R, Edwards A, Flemington EK, Zhang K. The sequence structures of human microRNA molecules and their implications. PLoS One 2013;8(1):e54215.
26. Saini HK, Enright AJ, Griffiths-Jones S. Annotation of mammalian primary microRNAs. BMC Genomics 2008;9:564.
27. Hitzler W, Vamvakas EC. Platelet microRNA profiles and the effect of pathogen reduction on platelet function. Clin Lab 2011; 57(7-8):451-454.
28. Bruchmuller I, Janetzko K, Bugert P, Mayaudon V, Corash L, Lin L, Kluter H. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates. Transfusion 2005; 45(9):1464-1472.
29. Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjorsvik S, Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gammairradiated single-donor platelet concentrates during long-term storage. Transfusion 2007;47(4):653-665.
30. Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Effects of a new pathogenreduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005;45(6):911-919.
31. Johnson L, Loh YS, Kwok M, Marks DC. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the Intercept blood system. Transfusion Med 2013; 23(2):121-129.
32. Carvalho H, Alguero C, Santos M, de Sousa G, Trindade H, Seghatchian J. The combined effect of platelet storage media and intercept pathogen reduction technology on platelet activation/ activability and cellular apoptosis/necrosis: Lisbon-RBS experience. Transfusion and apheresis science: Official journal of the World Apheresis Association: Official journal of the European Society for Haemapheresis 2006;34(2):187-192.
33. Tauszig ME, Picker SM, Gathof BS. Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction. Transfus Apher Sci 2012;46(1):33-37.
34. Picker SM, Speer R, Gathof BS. Functional characteristics of buffycoat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004;44(3):320-329.
35. Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hamotherapie) gema xx 12 und 18 des Transfusionsgesetzes (TFG), (A nderungen und Erganzungen 2010) vom 4. Mai 2010, Herausgegeben vom Bundesministerium der Justiz, Bundesanzeiger Nr. 101a, Jahrgang 62, 9. Juli 2010 (ISSN 0720-6100).
36. Nogawa M, Naito Y, Chatani M, Onodera H, Shiba M, Okazaki H, Matsuzaki K, Satake M, Nakajima K, Tadokoro K. Parallel comparison of apheresis-collected platelet concentrates stored in four different additive solutions. Vox Sang 2013; 105(4):305-312.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-408.
38. Perron MP, Landry P, Plante I, Provost P. Detection of human dicer and argonaute 2 catalytic activity. Methods Mol Biol 2011;725: 121-141.
39. Wyant TL, Smith PC, Brown B, Kantor AB. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets. Platelets 2001;12(5):309-318.
40. Van Peer G, Mestdagh P, Vandesompele J. Accurate RT-qPCR gene expression analysis on cell culture lysates. Sci Rep 2012;2:222.
41. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128(6):1173-1186.
42. Vogler M, Hamali HA, Sun XM, Bampton ET, Dinsdale D, Snowden RT, Dyer MJ, Goodall AH, Cohen GM. BCL2/ BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 2011; 117(26):7145-7154.
43. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7(2):157-161.
44. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-ODonnell E, Farndale RW, Ware J, et al. Platelets amplify inflammation in arthritis via collagendependent microparticle production. Science 2010; 327(5965):580-583.
45. Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, Provost P. Activated platelets can deliver mRNA regulatory Ago2microRNA complexes to endothelial cells via microparticles. Blood 2013;122(2):253-261.
46. Ple H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P. Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost 2012;108(4):605-615.
47. Stakos DA, Gatsiou A, Stamatelopoulos K, Tselepis AD, Stellos K. Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets. Platelets 2013; 24(8):579-589.
48. Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012;119(26):6288-6295.
49. van Rhenen DJ, Vermeij J, Mayaudon V, Hind C, Lin L, Corash L. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang 2000; 79(4):206-214.
50. Janetzko K, Lin L, Eichler H, Mayaudon V, Flament J, Kluter H. Implementation of the Intercept blood system for platelets into routine blood bank manufacturing procedures: Evaluation of apheresis platelets. Vox Sang 2004;86(4):239-245.
51. Bruchmuller I, Losel R, Bugert P, Corash L, Lin L, Kluter H, Janetzko K. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets. Platelets 2005; 16(8):441-445.
52. Li J, Lockerbie O, de Korte D, Rice J, McLean R, Goodrich RP. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion 2005; 45(6):920-926.
53. Matarrese P, Straface E, Palumbo G, Anselmi M, Gambardella L, Ascione B, Del Principe D, Malorni W. Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A-activation and long-term commitment to cell death. FEBS J 2009; 276(3):845-856.
54. Zharikov S, Shiva S. Platelet mitochondrial function: From regulation of thrombosis to biomarker of disease. Biochem Soc Trans 2013;41(1):118-123.
55. Keuren JF, Cauwenberghs S, Heeremans J, de Kort W, Heemskerk JW, Curvers J. Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006; 46(2):204-212.
56. Yuan JS, Reed A, Chen F, Stewart Jr CN. Statistical analysis of realtime PCR data. BMC Bioinformatics 2006;7:85.
57. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009;136(2):215-233.